MedPath

Effects of Insomnia on Simulated Driving (MK-0000-183-00)

Phase 1
Completed
Conditions
Insomnia
Interventions
Other: Placebo/ethanol (blinded)
Registration Number
NCT01209728
Lead Sponsor
Merck Sharp & Dohme LLC
Brief Summary

This is a double-blind, parallel design study in elderly primary insomnia patients and demographically matched controls. The objectives if this study are primarily: 1. To determine if functional deficits in simulated driving performance can be demonstrated in primary insomnia patients, and detected in healthy volunteers, impaired by alcohol; and secondarily: 2. To compare simulated driving performance deficits in elderly primary insomnia patients to those in healthy elderly volunteers impaired by alcohol, for at least one of the following driving endpoints: standard deviation of lane position (SDLP), standard deviation of speed (speed deviation), lane excursions, and a driving composite score.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
76
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Primary insomnia patients and healthy subjectsPlacebo/ethanol (blinded)Elderly participants, including primary insomnia patients and healthy subjects
Primary Outcome Measures
NameTimeMethod
Simulated driving variablesEvaluated on, up to, 3 different days, with 2 driving sessions of ~65 minutes each day.

Simulated driving variables which may include (standard deviation of lane position (SDLP), speed deviation, lane excursions, or a composite score of several driving variables).

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath